Suggestions
Marcus Hompesch
CEO & Chairman of the Board at ProSciento, Inc.
Professional Background
Dr. Marcus Hompesch is a prominent figure in the field of internal medicine and clinical research, particularly recognized for his expertise in Diabetology. With a rich educational background and extensive experience in both clinical settings and the health care industry, he has made significant contributions to diabetes management and clinical research. His journey began with a solid foundation in medicine, earning his M.D. from the prestigious University of Düsseldorf.
Following his medical education, Dr. Hompesch transitioned into a diverse array of roles that intertwined clinical practice with a passion for research and innovation. Starting in clinical and academic roles, he later took the entrepreneurial leap into the health care industry, where he focused on diabetes disease management software. This initial foray set the stage for his remarkable career in clinical research.
As a leader in the clinical research domain, he has been at the helm of several organizations, notably as the CEO and Chairman of the Board at ProSciento, Inc. Under his leadership, ProSciento has become a recognized powerhouse in clinical research dedicated to early-phase drug and device development in areas such as diabetes, NASH (Nonalcoholic Steatohepatitis), NAFLD (Nonalcoholic Fatty Liver Disease), and obesity. His work primarily targets the advancement of innovative therapies and technologies to address these pressing health challenges.
Education and Achievements
Dr. Hompesch pursued his medical studies at the University of Düsseldorf, where he gained expansive knowledge and hands-on experience that would later inform his clinical and research practices. Post-graduation, he held various significant positions that paved the way for his current leadership role. Among his many accomplishments, he has been instrumental in establishing and managing specialized clinical research organizations that are dedicated to improving patient outcomes through science-driven methodologies.
His expertise is particularly pronounced in the design of early-phase clinical studies, including meaningful mechanistic studies and proof-of-concept trials. Dr. Hompesch has played a vital role in advancing our understanding of the mechanisms underlying diabetes and its complications, leading to actionable insights that benefit both the scientific community and patient populations.
His previous positions include CEO at Profil Outpatient Trials GmbH and COO at Profil Institute for Metabolic Research GmbH, where he oversaw numerous clinical trials and contributed to the enhancement of research methodologies within the realm of diabetes management and related fields. Additionally, he founded MedIQ AG and MKD GmbH, further solidifying his reputation as a forward-thinking entrepreneur committed to advancing health care solutions.
Notable Contributions
Through his career, Dr. Hompesch has championed innovative approaches to clinical trials, shaping the landscape of early-phase research in diabetes and metabolic disorders. His leadership at ProSciento has been marked by a commitment to excellence and a results-oriented approach that emphasizes the importance of quality in clinical research. He has overseen Drug Development programs that bridge the gap between research and real-world applications, striving to develop safe and effective treatments to improve the lives of patients with diabetes and other metabolic diseases.
His scientific expertise in designing and implementing phase 1 and 2a clinical studies is widely recognized, making him a sought-after consultant and thought leader in his field. His contributions not only address the immediate challenges posed by diabetes but also pave the way for future breakthroughs in treatment protocols.
As a scientific associate at Ruhr University Bochum and as a physician at Klinikum Wuppertal, Dr. Hompesch has demonstrated a commitment to educating and mentoring the next generation of medical professionals in the fields of metabolic health. His approach combines clinical acumen with research innovations, ensuring that future practitioners are well-equipped to navigate the complexities of patient care and emerging scientific knowledge.
Overall, Dr. Marcus Hompesch stands out as a dedicated healthcare professional, researcher, and entrepreneur. His unwavering focus on improving diabetes care and management through ingenious research strategies and pioneering clinical studies remains an inspiration to colleagues in the field of medicine and beyond.
